Gland Pharma Limited — Others, 27-12-2024: Trading Window

Gland Pharma has announced a board meeting to consider the financial results for the quarter and nine months ending December 31, 2024. In preparation for this, the trading window for the company’s securities will be closed from December 28, 2024, until 48 hours after the financial results are declared. This closure is a standard procedure in compliance with insider trading regulations and aims to ensure fair trading practices. Investors may view this as a typical corporate governance step, with potential implications on sentiment as the results may influence stock performance and outlook.